Avita Medical share price tumbles 7% on declining Q1 revenue

The ASX healthcare share saw its net loss for the quarter increase 58% year-on-year.

| More on:
a medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.

Image source: Getty Images

Key points

  • Avita Medical share price falls on decreased Q1 2022 revenue
  • Operating expenses increased 21% year-on-year
  • The ASX healthcare share has sufficient cash reserves to fund operations for the next 12 months

The Avita Medical Inc (ASX: AVH) share price is down 7.2% to $1.62 in early trade.

Avita focuses on regenerative medicines. Its spray-on Recell medicine is used to treat burn patients.

Below we look at the ASX healthcare share’s first-quarter results for the three months ending 31 March (Q1 2022).

What was reported for the quarter?

The Avita Medical share price is sliding after the company a 14% decrease in revenue compared to Q1 2021. Revenue for the quarter came in at $7.5 million.

The company reported the decline was largely due to its recognition of $4.1 million in Biomedical Advanced Research and Development Authority (BARDA) related revenue in 2021.

Avita’s Q1 2022 commercial revenue increased 61% year-on-year to $2.8 million. It attributed the lift to “broader utilisation among our customer base as well as deeper penetration within individual customer accounts”.

Gross profits of $5.7 million were down 13% from the $6.6 million reported in the prior corresponding period. Gross profit margin of 76% was identical to Q1 2021.

Operating expenses increased $2.8 million to $16.0 million, 21% higher than the corresponding quarter.

On the bottom line, and likely pressuring the Avita Medical share price today, the company reported a net loss of $9.5 million. That’s 58% more than the $6.0 million net loss reported for the first three months of 2021.

What’s next?

The company intends to use its cash reserves until US sales of its products ramp up to levels where those revenues can fund its ongoing operations. As at 31 March, Avita reported it has enough cash reserves to fund operations for the next 12 months.

Avita added, “We have no committed plans to issue further shares on the market.”

As for dividends?

“There were no dividends paid and we have no plans to commence the payment of dividends.”

Avita Medical share price snapshot

With this morning’s intraday losses factored in, the Avita Medical share price is down a painful 53% in 2022. That compares to a year-to-date loss of 9% posted by the All Ordinaries Index (ASX: XAO).

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical Limited. The Motley Fool Australia has recommended Avita Medical Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A young man with short black fuzzy hair and wearing a black and white striped t-shirt looks surprised at the Neometals share price rising today
Earnings Results

Mesoblast share price spikes amid ‘substantial reduction in operational spend’

Mesoblast also completed the resubmission of its Biologics License Application (BLA) for remestemcel-L to the FDA last quarter.

Read more »

A doctor sits with a patient and uses a pen to point to certain parts of her mammogram scan
Earnings Results

Volpara share price up on record full-year results

ASX investors appear to be pleased with Volpara's results.

Read more »

Miner looking at his notes.
Earnings Results

Champion Iron share price falls on FY22 results

Champion Iron shares are under pressure on Thursday...

Read more »

Person with thumbs down and a red sad face poster covering the face.
Earnings Results

Here’s why the New Hope share price is tumbling 8% on Thursday

Coal prices have reached all-time highs amid Russia's war in Ukraine.

Read more »

a man sits at a bar leaning sadly on his basketball wearing a US flag sticker on his cheekbone near a half drunk beer and looking despondent as though his basketball team has just lost a game.
Earnings Results

Why is the Catapult share price tumbling 6% lower today?

Catapult shares are falling on Thursday following the release of its full-year results...

Read more »

Man with a sleep apnea mask on whilst sleeping.
Earnings Results

Fisher & Paykel share price exhales following ‘strong’ full-year results

The COVID-19 tailwind is beginning to taper off, but how did Fisher & Paykel perform in FY22?

Read more »

ASX share price on watch represented by woman investor looking at ASX financial results on laptop
Technology Shares

TechnologyOne share price slides despite strong first-half SaaS growth

TechnologyOne shares are falling falling the release of the company's half-year results...

Read more »

A woman stares at the candle on her cake, her birthday has fizzled.
Earnings Results

Incitec Pivot share price fizzles despite half-year earnings increasing tenfold

Explosive profits lose their firepower amid breakup plans inside Incitec.

Read more »